AMG 133 clinical trials

A Phase 2 Randomized, Placebo-controlled, Double-blind, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus.

This study is testing a new medicine, AMG 133, for adults who are overweight or have obesity, with or without type 2 diabetes. Researchers want to see if it helps with weight loss and if it's safe.